Abiopharma

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Amtech Systems Announces Proposed Public Offering of Common Stock

Epsilon Energy LTD. Announces Quarterly Dividend and Borrowing Base Redetermination

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Dave & Buster’s Entertainment, Inc. to Report First Quarter 2026 Financial Results on June 15, 2026

Penguin Solutions Announces CFO Transition